Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Miura

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
BMC Cancer|May 28, 2017
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604Yuki Misumi, Hiroaki Okamoto, Jiichiro Sasaki, et al.
Thoracic Cancer|October 4, 2022
Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutationsMio Kanbe, Noriaki Sunaga, Kenichiro Hara, et al.
Thoracic Cancer|June 30, 2025
Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective StudyAyako Shiono, Hisao Imai, Kyoichi Kaira, et al.
BMC Pulmonary Medicine|April 8, 2024
A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositisMasakiyo Yatomi, Keiichi Akasaka, Shintaro Sato, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
BMC Cancer|May 28, 2017
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604Yuki Misumi, Hiroaki Okamoto, Jiichiro Sasaki, et al.
Thoracic Cancer|October 4, 2022
Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutationsMio Kanbe, Noriaki Sunaga, Kenichiro Hara, et al.
Thoracic Cancer|June 30, 2025
Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective StudyAyako Shiono, Hisao Imai, Kyoichi Kaira, et al.
BMC Pulmonary Medicine|April 8, 2024
A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositisMasakiyo Yatomi, Keiichi Akasaka, Shintaro Sato, et al.
Pageof 5